Mauna Kea Technologies : Success and Strong Attendance for Cellvizio at the...
PARIS Regulatory News : Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary optical biopsy platform, announces a strong presence at the...
View ArticleAHF India Urges Prime Minister Modi to Restore Drug Price Caps
NEW DELHI AIDS Healthcare Foundation (AHF), the largest global AIDS organization, with its affiliate country program, AHF India, today urged Indian Prime Minister Narendra Modi to restore drug...
View ArticleAdvanced Biological Laboratories, The University of Hong Kong and The Hong...
LUXEMBOURG & HONG KONG Advanced Biological Laboratories (ABL), S.A, The University of Hong Kong and The Hong Kong Polytechnic University are today launching their collaborative tuberculosis (TB)...
View ArticleAscom Myco Brings the Mobile Revolution to Nursing Care
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 GOTHENBURG, Sweden Ascom Wireless Solutions, a global provider of mission-critical communication systems, has introduced a revolution in...
View ArticleCovidien促进全球提高对血栓风险的知晓度
爱尔兰都柏林 (美国商业资讯)– Covidien plc今天宣布,该公司将作为全球伙伴,支持世界血栓日的启动活动,这是全球应对静脉血栓栓塞(VTE)威胁的努力的一部分。国际血栓和瘀血学会(ISTH)将于2014年10月13日展开该活动,藉此契机凸显VTE的负担和病损及死亡风险1。 ISTH主席、UNC Health Care和UNC医学院血液科医生Nigel...
View Article米国ボストン・ストラテジクス社:制がん剤臨床試験で採取された患者さんの腫瘍組織を駆使したトランスレーショナル研究に関して米国モレキュラー・レスポンス社との...
ボストン (ビジネスワイヤ) — 米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発会社...
View ArticleBioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan...
YOKOHAMA, Japan BioNet-Asia’s CEO, Dr Pham Hong Thai provided today an update on the company lead vaccine program in his presentation at BioJapan 2014. Dr Pham said that the current Phase I/II trial...
View ArticleFocus on Excellence in Endoscopy: PENTAX Medical at UEGW 2014
HAMBURG, Germany PENTAX Medical will be presenting the latest technologies and programmes designed to ensure excellence in endoscopy on Stand 9, Hall Y at UEGW 2014, Vienna, 18th-22nd October....
View ArticleClinical Trial at Kyoto Medical Center Proves Efficacy of Curcumin in Knee...
KYOTO, Japan The Orthopedics Division at National Hospital Organization, Kyoto Medical Center, announced that it has confirmed the efficacy of Theracrumin®, absorption enhanced curcumin*1 on knee...
View ArticleDr. Reddy’s to Release Q2 FY15 Results on October 29, 2014
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2014 on Wednesday, October 29, 2014 after the Board Meeting. The results will...
View ArticlePanasonic Celebrates 35 Years in China
BEIJING On October 14, 2014 Panasonic Corporation of China celebrated 35 years in China in a celebration held at the China World Hotel Beijing. Approximately 300 government officials, partners,...
View ArticleR-Tech Ueno: Announcement of Initiation of the Phase I Clinical Trial for the...
TOKYO R-Tech Ueno (JASDAQ: 4573): We are pleased to announce that as of today, the company has started the phase one clinical trial for the new molecular entity RTU-1096, which is a vascular...
View ArticlePersonalis and the Garvan Institute Announce Commercial Partnership for Whole...
MENLO PARK, Calif. & SYDNEY Personalis, Inc., a leading genomics-based clinical research and diagnostics global service provider based in the USA, and the Garvan Institute of Medical Research in...
View Article昆泰荣获临床研究中心协会颁发的2014年鹰奖
北卡罗来纳州三角研究园 (美国商业资讯)–昆泰(Quintiles)今天宣布该公司荣获临床研究中心协会(Clinical Research Sites, SCRS)颁发的2014年临床研究机构(CRO)鹰奖(Eagle Award)。该奖项在年度SCRS研究中心解决方案峰会(Site Solutions Summit)上颁发,旨在表彰卓越的领导力、专业性、诚信、热情和奉献精神。...
View ArticleHumacyte Selected to Join U.S. Secretary of Commerce On Trade Mission to Asia
RESEARCH TRIANGLE PARK, N.C. Humacyte, a pioneer in regenerative medicine, today announced it will join U.S. Secretary of Commerce Penny Pritzker on a Development Mission to Japan and South Korea...
View ArticleHatchtech Announces Successful Results from Phase 2 Ovicidal Study
MELBOURNE, Australia Specialty pharmaceutical company Hatchtech Pty Ltd today announced positive results from a Phase 2 clinical study evaluating the ovicidal efficacy (ability to kill lice eggs) of...
View ArticleGVK BIO宣布成功完成药物创新应用,以确定新的适应证
印度海德拉巴德 (美国商业资讯)–亚洲领先的整合式发现研发组织GVK Biosciences (GVK BIO)今天宣布,采用GVK BIO拥有专利的药物创新应用(Drug Repurposing)平台,为武田制药株式会社(Takeda Pharmaceutical Company...
View Article